1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.PMID:
8861899.
2. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6-21.PMID:
11782440.
3. Russo VEA, Martienssen RA, Riggs AD. Epigenetic mechanisms of gene regulation. New York: Cold Spring Harbor Laboratory Press, 1996.
4. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-167.PMID:
9988266.
5. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-2054.PMID:
14627790.
6. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007;8:286-298.PMID:
17339880.
7. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-1159.PMID:
18337604.
8. Chedin F, Lieber MR, Hsieh CL. The DNA methyltransferaselike protein DNMT3L stimulates
de novo methylation by Dnmt3a. Proc Natl Acad Sci U S A 2002;99:16916-16921.PMID:
12481029.
10. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683-692.PMID:
17320506.
11. Wajed SA, Laird PW, DeMeester TR. DNA methylation: an alternative pathway to cancer. Ann Surg 2001;234:10-20.PMID:
11420478.
12. Gu M, Kim D, Bae Y, Choi J, Kim S, Song S. Analysis of microsatellite instability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas. Hepatogastroenterology 2009;56:899-904.PMID:
19621725.
13. Kane MF, Loda M, Gaida GM, et al. Methylation of the
hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57:808-811.PMID:
9041175.
14. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-9826.PMID:
8790415.
15. Esteller M, Silva JM, Dominguez G, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000;92:564-569.PMID:
10749912.
16. Merlo A, Herman JG, Mao L, et al. 5'CpG island methylation is associated with transcriptional silencing of the tumour suppressor
p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-692.PMID:
7585152.
17. Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 1989;83:155-158.PMID:
2550354.
18. Chan TA, Glockner S, Yi JM, et al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med doi:
10.1371/journal.pmed.0050114. Published online 27 May 2008.
19. Schuebel KE, Chen W, Cope L, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007;3:1709-1723.PMID:
17892325.
20. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983;301:89-92.PMID:
6185846.
21. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002;99:3740-3745.PMID:
11891299.
22. Bird A. The essentials of DNA methylation. Cell 1992;70:5-8.PMID:
1377983.
23. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003;300:455PMID:
12702868.
24. Rodriguez J, Frigola J, Vendrell E, et al. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 2006;66:8462-9468.PMID:
16951157.
25. Fraga MF, Herranz M, Espada J, et al. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 2004;64:5527-5534.PMID:
15313885.
26. Antequera F, Bird A. CpG islands. EXS 1993;64:169-185.PMID:
8418949.
27. Lim DH, Maher ER. Genomic imprinting syndromes and cancer. Adv Genet 2010;70:145-175.PMID:
20920748.
28. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet 2010;70:27-56.PMID:
20920744.
29. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.PMID:
20192811.
30. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-1517.PMID:
15168363.
31. Thia KT, Loftus EV Jr. SandbornWJ. YangSK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167-3182.PMID:
19086963.
32. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001;293:1068-1070.PMID:
11498573.
33. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.PMID:
17653185.
34. Kim JM. Antimicrobial proteins in intestine and inflammatory bowel diseases. Intest Res 2014;12:20-33.PMID:
25349560.
38. Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell 1999;99:451-454.PMID:
10589672.
39. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010;465:721-727.PMID:
20535201.
40. Gloria L, Cravo M, Pinto A, et al. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 1996;78:2300-2306.PMID:
8940998.
41. Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16
INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998;58:3942-3945.PMID:
9731506.
42. Tahara T, Shibata T, Nakamura M, et al. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int J Mol Med 2009;23:521-527.PMID:
19288029.
43. Kim TO, Park J, Kang MJ, et al. DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis. Int J Mol Med 2013;31:1255-1261.PMID:
23546389.
44. Lin Z, Hegarty JP, Cappel JA, et al. Identification of diseaseassociated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Clin Genet 2011;80:59-67.PMID:
20950376.
45. Cooke J, Zhang H, Greger L, et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2128-2137.PMID:
22419656.
46. Saito S, Kato J, Hiraoka S, et al. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm Bowel Dis 2011;17:1955-1965.PMID:
21830274.
47. Bae JH, Park J, Yang KM, Kim TO, Yi JM. Detection of DNA hypermethylation in sera of patients with Crohn's disease. Mol Med Rep 2014;9:725-729.PMID:
24317008.
48. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:e32PMID:
10734209.
49. Uhlmann K, Brinckmann A, Toliat MR, Ritter H, Nurnberg P. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis 2002;23:4072-4079.PMID:
12481262.
51. Caballero OL, Chen YT. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 2009;100:2014-2021.PMID:
19719775.
52. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-266.PMID:
12671664.
53. Glockner SC, Dhir M, Yi JM, et al. Methylation of
TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009;69:4691-4699.PMID:
19435926.
54. Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008;54:414-423.PMID:
18089654.
55. Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008;358:1118-1128.PMID:
18337602.
56. Yi JM, Dhir M, Van Neste L, et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res 2011;17:1535-1545.PMID:
21278247.
57. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-797.PMID:
10029064.
58. Harris RA, Nagy-Szakal D, Pedersen N, et al. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:2334-2341.PMID:
22467598.
59. Lin Z, Hegarty JP, Yu W, et al. Identification of disease-associated DNA methylation in B cells from Crohn's disease and ulcerative colitis patients. Dig Dis Sci 2012;57:3145-3153.PMID:
22821069.
60. Nimmo ER, Prendergast JG, Aldhous MC, et al. Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm Bowel Dis 2012;18:889-899.PMID:
22021194.
61. Kim SW, Kim ES, Moon CM, Kim TI, Kim WH, Cheon JH. Abnormal genetic and epigenetic changes in signal transducer and activator of transcription 4 in the pathogenesis of inflammatory bowel diseases. Dig Dis Sci 2012;57:2600-2607.PMID:
22569826.
62. Hasler R, Feng Z, Backdahl L, et al. A functional methylome map of ulcerative colitis. Genome Res 2012;22:2130-2137.PMID:
22826509.